Application of Omega-3 or pharmaceutically acceptable fatty acid thereof to improvement of spermatogenesis disorder

A technology of spermatogenesis disorder and fatty acid, applied in the field of biomedicine, can solve the problems of poorly understood cellular and molecular mechanisms of spermatogonial regeneration

Pending Publication Date: 2022-03-08
NANJING MEDICAL UNIV +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are many factors that promote spermatogenesis in mice, the cellular and molecular mechanisms underlying spermatogonial regeneration remain poorly understood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Omega-3 or pharmaceutically acceptable fatty acid thereof to improvement of spermatogenesis disorder
  • Application of Omega-3 or pharmaceutically acceptable fatty acid thereof to improvement of spermatogenesis disorder
  • Application of Omega-3 or pharmaceutically acceptable fatty acid thereof to improvement of spermatogenesis disorder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] This example is based on the results of targeted metabolomics detection of eicosanoids in testis tissue in the NOA model group induced by busulfan and the Omega-3 administration group. Significantly elevated in tissues, such as figure 1 and 2 As shown, the recovery potential of Omega-3 administered NOA mice to spermatogenesis disorder was further verified.

[0048] The specific verification steps are as follows:

[0049] 1. Selection of experimental materials:

[0050] B6 common mice, male, weighing 20-25 g, 5 weeks old, SPF grade were selected as animals; Omega-3 was selected from Chengdu Guowei Biomedical Co., Ltd.

[0051] 2. Raising conditions for mice:

[0052] All mice were free to forage for food and drink water, and were reared at a room temperature of 25±2°C and a relative humidity of 40%-70%; light and dark alternated for 12 hours, and the experiment began after the mice were adaptively fed for one week.

[0053] 3. Mouse grouping and model setting:

[005...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel application of Omega-3 or pharmaceutically acceptable fatty acid thereof, and the novel application comprises an application of Omega-3 or pharmaceutically acceptable fatty acid thereof in preparation of a medicine for treating NOA. Through eicosanoic acid targeted metabonomics, it is screened that DHA and EPA in testicular tissue of a polyunsaturated fatty acid Omega-3 gavage male mouse are obviously up-regulated. Experiments prove that Omega-3 is injected into the stomach of a busulfan-induced NOA mouse, the thickness and integrity of testis recovery spermatogenic epithelium and the concentration of epididymis tail sperms can be observed, and meanwhile, proliferation and differentiation of spermatogonium and expression of supporting cell paracrine factors are promoted, so that the Omega-3 can be used as a new target for improving the NOA mouse testis spermatogenic dysfunction; a novel method is provided for treating the non-obstructive azoospermia.

Description

technical field [0001] The invention belongs to the field of biomedicine, and specifically relates to the application of polyunsaturated fatty acid Omega-3 or its pharmaceutically acceptable fatty acid in improving spermatogenesis disorder. Background technique [0002] Male infertility has become an important issue in human health. Globally, more than 10% of couples are infertile, and male factor accounts for half of infertility. The most common cause of male infertility is primary testicular dysfunction, usually characterized by abnormal spermatogenesis, clinically manifested as non-obstructive azoospermia (NOA). [0003] Spermatogenesis is the precise process by which spermatogonia produce sperm cells through the stages of mitosis, meiosis, spermatogenesis, and sperm release. Spermatogenesis is regulated by a unique testicular microenvironment composed of Sertoli cells, stromal cells, peritubular myoid cells and their secretory bodies, including bone morphogenetic prote...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/202A61P15/08
CPCA61K31/202A61P15/08
Inventor 姚兵靖俊李朝军邹志川吴菁冯雨明马金召马汝钧戈榭陈莉
Owner NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap